How should RT be combined with immunotherapy to generate an abscopal response?
Is there any consensus regarding the optimal RT dose, fractionation, and timing to the best abscopal response? What is the optimal metastatic site to treat if the patients has multiple metatastatic lesions?
Answer from: Radiation Oncologist at Academic Institution
This is a difficult question to answer because cancer "immunotherapy" is really a variety of heterogeneous therapeutic approaches. Nevertheless, I am aware of no consensus that specifies the optimal radiotherapy dose, fractionation, timing, or target, when used in conjuncti...